Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
Erkan Cüre, Medine Cumhur Cüre
Topics & Concepts
Diabetes mellitusMedicineRostral ventrolateral medullaRenin–angiotensin systemInternal medicineHeart failureEndocrinologyAngiotensin-converting enzyme 2Sympathetic nervous systemAngiotensin IICardiologyBlood pressureDiseaseCoronavirus disease 2019 (COVID-19)Heart rateInfectious disease (medical specialty)COVID-19 Clinical Research StudiesApelin-related biomedical researchLong-Term Effects of COVID-19